A citation-based method for searching scientific literature

Núria Alonso, María Teresa Julián, Jorge Carrascal, Roger Colobran, Irma Pujol-Autonell, Silvia Rodriguez-Fernández, Aina Teniente, Marco Antonio Fernández, Antoni Miñarro, María Carmen Ruiz de Villa, Marta Vives-Pi, Manel Puig-Domingo. PLoS One 2015
Times Cited: 7







List of co-cited articles
76 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Lei Tian, Jie Gao, Jianqiang Hao, Yu Zhang, Huimin Yi, Timothy D O'Brien, Robert Sorenson, Jian Luo, Zhiguang Guo. Endocrinology 2010
89
100

Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
74
85

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin.
Marcos M Lima-Martínez, Ernesto Guerra-Alcalá, Miguel Contreras, José Nastasi, Janelle A Noble, Constantin Polychronakos. Endocrinol Diabetes Metab Case Rep 2014
14
85

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, Michael Mark, Thomas Klein. J Endocrinol 2012
38
71

Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3.
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Margareth Afonso Torres. Endocrinol Diabetes Metab Case Rep 2016
17
71

Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.
S L Ellis, E G Moser, J K Snell-Bergeon, A S Rodionova, R M Hazenfield, S K Garg. Diabet Med 2011
89
71

Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Marcelo Maia Pinheiro, Caroline Lais Stoppa, Claudete Justina Valduga, Cristina Eunice Okuyama, Renata Gorjão, Regina Mara Silva Pereira, Susana Nogueira Diniz. Eur J Pharm Sci 2017
40
71

Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).
Takuya Awata, Akira Shimada, Taro Maruyama, Yoichi Oikawa, Nobuyuki Yasukawa, Susumu Kurihara, Yumi Miyashita, Masako Hatano, Yuichi Ikegami, Masafumi Matsuda,[...]. Diabetes Ther 2017
25
71

Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
Lei Ding, Conny A Gysemans, Geert Stangé, Yves Heremans, Yixing Yuchi, Tatiana Takiishi, Hannelie Korf, Marie Chintinne, Richard D Carr, Harry Heimberg,[...]. PLoS One 2014
15
57




Combined treatment with sitagliptin and vitamin D in a patient with latent autoimmune diabetes in adults.
E Rapti, S Karras, M Grammatiki, A Mousiolis, X Tsekmekidou, E Potolidis, P Zebekakis, M Daniilidis, K Kotsa. Endocrinol Diabetes Metab Case Rep 2016
21
57


C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study.
Odd Erik Johansen, Bernhard O Boehm, Valdemar Grill, Peter A Torjesen, Sudipta Bhattacharya, Sanjay Patel, Kristiane Wetzel, Hans-Juergen Woerle. Diabetes Care 2014
41
57

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Satish K Garg, Emily G Moser, Bruce W Bode, Leslie J Klaff, William R Hiatt, Christie Beatson, Janet K Snell-Bergeon. Endocr Pract 2013
68
57

Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).
R Buzzetti, P Pozzilli, R Frederich, N Iqbal, B Hirshberg. Diabetes Metab Res Rev 2016
31
57

Sitagliptin in glutamic acid decarboxylase antibody-positive diabetes mellitus.
Narayanan Kandasamy, Graham Lennox, Anand K Annamalai, Gerald Maguire, Amanda I Adler. Endocr Pract 2012
9
42

Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26).
Bertram Bengsch, Bianca Seigel, Tobias Flecken, Julia Wolanski, Hubert E Blum, Robert Thimme. J Immunol 2012
104
42

Significant elevation of serum dipeptidyl peptidase-4 activity in young-adult type 1 diabetes.
Saeko Osawa, Dan Kawamori, Naoto Katakami, Mitsuyoshi Takahara, Fumie Sakamoto, Takashi Katsura, Tetsuyuki Yasuda, Hideaki Kaneto, Munehide Matsuhisa, Taka-Aki Matsuoka,[...]. Diabetes Res Clin Pract 2016
18
42

The DPP-4 inhibitor linagliptin restores β-cell function and survival in human isolated islets through GLP-1 stabilization.
Payal Shah, Amin Ardestani, Gitanjali Dharmadhikari, Svenja Laue, Desiree M Schumann, Julie Kerr-Conte, Francois Pattou, Thomas Klein, Kathrin Maedler. J Clin Endocrinol Metab 2013
65
42

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.
Shelley Lindley, Colin M Dayan, Amanda Bishop, Bart O Roep, Mark Peakman, Timothy I M Tree. Diabetes 2005
602
42


Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus.
Atsushi Iwabuchi, Tomohiro Kamoda, Makoto Saito, Hiroki Nozue, Isho Izumi, Takeki Hirano, Ryo Sumazaki. J Pediatr Endocrinol Metab 2013
19
42

Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
62
42

Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.
A D Dobrian, Q Ma, J W Lindsay, K A Leone, K Ma, J Coben, E V Galkina, J L Nadler. Am J Physiol Endocrinol Metab 2011
110
42

Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes.
Tímea Varga, Anikó Somogyi, Gábor Barna, Barna Wichmann, Géza Nagy, Károly Rácz, László Selmeci, Gábor Firneisz. Pathol Oncol Res 2011
40
42

Sitagliptin exerts an antinflammatory action.
Antoine Makdissi, Husam Ghanim, Mehul Vora, Kelly Green, Sanaa Abuaysheh, Ajay Chaudhuri, Sandeep Dhindsa, Paresh Dandona. J Clin Endocrinol Metab 2012
174
42

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
J Andrew Pospisilik, Jennifer Martin, Timothy Doty, Jan A Ehses, Nathalie Pamir, Francis C Lynn, Shalea Piteau, Hans-Ulrich Demuth, Christopher H S McIntosh, Raymond A Pederson. Diabetes 2003
273
42

Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
A Steinbrecher, D Reinhold, L Quigley, A Gado, N Tresser, L Izikson, I Born, J Faust, K Neubert, R Martin,[...]. J Immunol 2001
124
28

CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently.
C Klemann, J Schade, R Pabst, S Leitner, J Stiller, S von Hörsten, M Stephan. Clin Exp Immunol 2009
30
28

The structure and function of CD26 in the T-cell immune response.
C Morimoto, S F Schlossman. Immunol Rev 1998
335
28


Type 1 diabetes.
Mark A Atkinson, George S Eisenbarth, Aaron W Michels. Lancet 2014
28

Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
Zhiguang Zhou, Yufei Xiang, Linong Ji, Weiping Jia, Guang Ning, Gan Huang, Lin Yang, Jian Lin, Zhenqi Liu, William A Hagopian,[...]. Diabetes 2013
142
28

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.
Sheng Chen, Gary P Sims, Xiao Xiang Chen, Yue Ying Gu, Shunle Chen, Peter E Lipsky. J Immunol 2007
639
28

Treg activation defect in type 1 diabetes: correction with TNFR2 agonism.
Yoshiaki Okubo, Heather Torrey, John Butterworth, Hui Zheng, Denise L Faustman. Clin Transl Immunology 2016
63
28

Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study.
Urmila Anil Kagal, Netravathi Basavaraj Angadi, Somnath Mallikarjun Matule. Int J Appl Basic Med Res 2017
15
28

Pathogenic T helper type 17 cells contribute to type 1 diabetes independently of interleukin-22.
S M Bellemore, E Nikoopour, O Krougly, E Lee-Chan, L A Fouser, B Singh. Clin Exp Immunol 2016
23
28

Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.
Wendy Dankers, Edgar M Colin, Jan Piet van Hamburg, Erik Lubberts. Front Immunol 2017
156
28




C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Carlos E B Couri, Maria C B Oliveira, Ana B P L Stracieri, Daniela A Moraes, Fabiano Pieroni, George M N Barros, Maria Isabel A Madeira, Kelen C R Malmegrim, Maria C Foss-Freitas, Belinda P Simões,[...]. JAMA 2009
269
28

Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
Xia Li, Lan Liao, Xiang Yan, Gan Huang, Jian Lin, Minxiang Lei, Xiangbing Wang, Zhiguang Zhou. Diabetes Metab Res Rev 2009
70
28



The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.
Yunjuan Zhao, Lin Yang, Xiangbing Wang, Zhiguang Zhou. Diabetes Metab Res Rev 2014
39
28

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study.
E Hyppönen, E Läärä, A Reunanen, M R Järvelin, S M Virtanen. Lancet 2001
28

CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1.
Kei Ohnuma, Tadanori Yamochi, Masahiko Uchiyama, Kunika Nishibashi, Noritada Yoshikawa, Noriaki Shimizu, Satoshi Iwata, Hirotoshi Tanaka, Nam H Dang, Chikao Morimoto. Proc Natl Acad Sci U S A 2004
89
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.